COPING with FTD by Cindy Odell
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
1:03-Cv-03578 Document #: 199 Filed: 09/08/06 Page 1 of 136 Pageid
Case: 1:03-cv-03578 Document #: 199 Filed: 09/08/06 Page 1 of 136 PageID #:<pageID> IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION FEDERAL TRADE COMMISSION, ) ) Plaintiff, ) Case No. 03 C 3578 ) v. ) Magistrate Judge Morton Denlow ) QT, INC., Q-RAY COMPANY, ) BIO-METAL, INC., QUE TE PARK, ) a.k.a. ANDREW Q. PARK, and ) JUNG JOO PARK, ) ) Defendants. ) MEMORANDUM OPINION AND ORDER “The pain just went away.” “Within seconds the pain was gone.” “You don’t have to live with pain.” The Q-Ray® Ionized Bracelet® (“Q-Ray bracelet”) achieved tremendous commercial success through a series of 30-minute infomercials. The Federal Trade Commission (“FTC”) brings this action claiming Defendants marketed the Q-Ray bracelet in a deceptive and misleading manner by representing that the bracelet provides immediate, significant or complete pain relief and scientific tests prove their pain-relief claims. Defendants deny their advertising was false or misleading. They contend adequate substantiation exists for the advertising claims made in connection with the promotion and sale of the Q-Ray bracelet. Case: 1:03-cv-03578 Document #: 199 Filed: 09/08/06 Page 2 of 136 PageID #:<pageID> The Court conducted a seven-day bench trial between June 6 and July 11, 2006. The Court has carefully considered the testimony of the witnesses who testified in person and by deposition, the Joint Stipulations of Fact for Trial, the exhibits introduced into evidence, the written submissions of the parties, and the oral arguments of counsel. The counsel on both sides presented the case in a highly professional manner. -
Antipsychotic Medication Reduction
So tonight we'll be discussing antipsychotic medication reduction. I'm happy to share some of my experiences with this challenging initiative and in nursing homes. I have no financial affiliations to disclose. And for our objectives and our agenda today, we're going to assess and evaluate appropriate antipsychotic medication use in nursing home residents, and apply strategies toward behavior management and antipsychotic medication reduction. The first part of the program we'll look at current trends and rates of antipsychotic medication use. We'll discuss the CMS initiative and latest policy issues. And then we'll look at a couple case studies. So first off, this first graph goes over the national progress in reducing the inappropriate use of antipsychotic medications in nursing homes. The taller red bar gives us the 2011 baseline number of 23.9%. That's a dotted red line indicates the start of the 2012 CMS initiative. That's the National Partnership to Improve Dementia Care in Nursing Homes. The latest information all the way down at the end is from the third quarter of 2018, which shows that nationally we have a 14.6% use rate. Overall, this looks like a reduction of nearly 40% since the initiative began. Overall though, I think this is great progress. Why should we be concerned with antipsychotic medications at all in this population? I have to say, that when I first exited my training from psychiatry and geriatric psychiatry, the black box warning had not yet come out. And it hit me that most of all the training that I learned was getting reversed when I entered the care setting. -
Psychotropic Medication Concerns When Treating Individuals with Developmental Disabilities
Tuesday, 2:30 – 4:00, C2 Psychotropic Medication Concerns when Treating Individuals with Developmental Disabilities Richard Berchou 248-613-6716 [email protected] Objective: Identify effective methods for the practical application of concepts related to improving the delivery of services for persons with developmental disabilities Notes: Medication Assistance On-Line Resources OBTAINING MEDICATION: • Needy Meds o Needymeds.com • Partnership for Prescriptions Assistance o Pparx.org • Patient Assistance Program Center o Rxassist.org • Insurance coverage & Prior authorization forms for most drug plans o Covermymeds.com REMINDERS TO TAKE MEDICATION: • Medication reminder by Email, Phone call, or Text message o Sugaredspoon.com ANSWER MOST QUESTIONS ABOUT MEDICATIONS: • Univ. of Michigan/West Virginia Schools of Pharmacy o Justaskblue.com • Interactions between medications, over-the-counter (OTC) products and some foods; also has a pictorial Pill Identifier: May input an entire list of medications o Drugs.com OTHER TRUSTED SITES: • Patient friendly information about disease and diagnoses o Mayoclinic.com, familydoctor.org • Package inserts, boxed warnings, “Dear Doctor” letters (can sign up to receive e- mail alerts) o Dailymed.nlm.nih.gov • Communications about drug safety o www.Fda.gov/cder/drug/drugsafety/drugindex.htm • Purchasing medications on-line o Pharnacychecker.com Updated 2013 Psychotropic Medication for Persons with Developmental Disabilities April 23, 2013 Richard Berchou, Pharm. D. Assoc. Clinical Prof., Dept. Psychiatry & Behavioral -
CHAPTER 6 Sleep and Stroke G.J
CHAPTER 6 Sleep and Stroke G.J. Meskill*, C. Guilleminault** *Comprehensive Sleep Medicine Associates, Houston, TX, USA **The Stanford Center for Sleep Sciences and Medicine, Redwood City, CA, USA OUTLINE Introduction 115 Stroke, Parasomnias, and Sleep- Related Movement Disorders 120 Sleep Apnea is a Risk Factor for Stroke 115 Diagnosis 120 Pathophysiology 116 Treatment 122 Stroke Increases the Risk of Sleep Apnea 118 Conclusions 123 Stroke and the Sleep–Wake Cycle 118 References 124 INTRODUCTION Stroke, defined as a focal neurological deficit of acute onset and vascular origin, is the sec- ond leading cause of death worldwide and is a major source of physical, psychological, and monetary hardship. There are more than 15 million cases worldwide annually, and 795,000 in the United States alone. In total, 137,000 stroke patients will die from stroke complications, and more than 50% will have physical and mental impairment.1 Factoring healthcare services, medications, and productivity loss, strokes cost the United States $34 billion annually.2 SLEEP APNEA IS A RISK FACTOR FOR STROKE Obstructive sleep apnea (OSA) is characterized by recurrent episodes of partial or complete interruption in breathing during sleep due to increased upper airway resistance. OSA has been identified as an independent risk factor for several cardiovascular and cerebrovascular Sleep and Neurologic Disease. http://dx.doi.org/10.1016/B978-0-12-804074-4.00006-6 Copyright © 2017 Elsevier Inc. All rights reserved. 115 116 6. SLEEP AND STROKE morbidities, including hypertension, ischemic heart disease, heart failure, atrial fibrillation, and hypertrophic cardiomyopathy.3–6 The incidence of OSA varies due to significant differ- ences in the sensitivity of testing sites, testing modalities (e.g., in-laboratory polysomnog- raphy vs. -
Treatment of Patients with Alzheimer's Disease and Other Dementias
PRACTICE GUIDELINE FOR THE Treatment of Patients With Alzheimer’s Disease and Other Dementias Second Edition WORK GROUP ON ALZHEIMER’S DISEASE AND OTHER DEMENTIAS Peter V. Rabins, M.D., M.P.H., Chair Deborah Blacker, M.D., Sc.D. Barry W. Rovner, M.D. Teresa Rummans, M.D. Lon S. Schneider, M.D. Pierre N. Tariot, M.D. David M. Blass, M.D., Consultant STEERING COMMITTEE ON PRACTICE GUIDELINES John S. McIntyre, M.D., Chair Sara C. Charles, M.D., Vice-Chair Daniel J. Anzia, M.D. Ian A. Cook, M.D. Molly T. Finnerty, M.D. Bradley R. Johnson, M.D. James E. Nininger, M.D. Barbara Schneidman, M.D. Paul Summergrad, M.D. Sherwyn M. Woods, M.D., Ph.D. AREA AND COMPONENT LIAISONS Joseph Berger, M.D. (Area I) C. Deborah Cross, M.D. (Area II) Harry A. Brandt, M.D. (Area III) Philip M. Margolis, M.D. (Area IV) John P. D. Shemo, M.D. (Area V) Barton J. Blinder, M.D. (Area VI) David L. Duncan, M.D. (Area VII) Mary Ann Barnovitz, M.D. Anthony J. Carino, M.D. Zachary Z. Freyberg, M.D., Ph.D. Sheila Hafter Gray, M.D. Tina Tonnu, M.D. Copyright 2010, American Psychiatric Association. APA makes this practice guideline freely available to promote its dissemination and use; however, copyright protections are enforced in full. No part of this guideline may be reproduced except as permitted under Sections 107 and 108 of U.S. Copyright Act. For permission for reuse, visit APPI Permissions & Licensing Center at http://www.appi.org/CustomerService/Pages/Permissions.aspx. -
October 1983
VOL. 7, NO. 10 Cover Photo by Rick Malkin FEATURES ALEX VAN HALEN Rock musicians are often accused of being more concerned with the rock 'n' roll lifestyle than with the music. That lifestyle is very much a part of Alex Van Halen's image, but underneath that image is a serious musician who has a lot to say about drums and drumming, and he says it here in this MD exclusive. by Robyn Flans 8 PHILLIP WILSON For a drummer to have played with such diverse groups as The Art Ensemble of Chicago and the Paul Butterfield Blues Band indicates that his musicianship is not limited in any way, and that is certainly true of Phillip Wilson, who has a knack for weaving seemingly contrasting influences together into one unique style. by Chip Stern 16 DRUMS AROUND THE WORLD Japan's Stomu Yamash'ta; England's Ronnie Verrell; Brazil's Ivan Conti; Canada's Steve Negus; Israel's Aron Kaminski; Den- mark's Alex Riel. 20 FRANK BEARD In this revealing interview, Frank Beard, the unpretentious, self-taught drummer for ZZ Top, discusses his career from his early emulations of '60s British rock bands, to his later involvement with a psychedelic group, and his present position as a member of the highly successful, Texas-based rock trio. by Susan Alexander 26 ROCK CHARTS COLUMNS "Lowdown In the Street" PROFILES 74 by James Morton ON THE MOVE Nelson Montana 30 ROCK PERSPECTIVES A Left-Handed Perspective REVIEWS EDUCATION by Robert Doyle 92 ON TRACK 94 CLUB SCENE STRICTLY TECHNIQUE PRINTED PAGE 96 Handling the Ups and Downs Triplets With Buzz Rolls 46 by Joe Morello by Rick Van Horn 100 NEWS COMPLETE PERCUSSIONIST UPDATE Junkanoo EQUIPMENT by Robyn Flans 110 by Neil M. -
Sundowning Behavior and Nonpharmacological Intervention Migmar Wangchuk
University of North Dakota UND Scholarly Commons Nursing Capstones Department of Nursing 2-4-2018 Sundowning Behavior and Nonpharmacological Intervention Migmar Wangchuk Follow this and additional works at: https://commons.und.edu/nurs-capstones Recommended Citation Wangchuk, Migmar, "Sundowning Behavior and Nonpharmacological Intervention" (2018). Nursing Capstones. 276. https://commons.und.edu/nurs-capstones/276 This Independent Study is brought to you for free and open access by the Department of Nursing at UND Scholarly Commons. It has been accepted for inclusion in Nursing Capstones by an authorized administrator of UND Scholarly Commons. For more information, please contact [email protected]. Running head: NON-PHARMACOLOGICAL INTERVENTION FOR SUNDONWING 1 Sundowning Behavior and Nonpharmacological Intervention Migmar Wangchuk Master of Science in Nursing, University of North Dakota, 2018 An Independent Study Submitted to the Graduate Faculty of the University of North Dakota in partial fulfillment of the requirements for the degree of Master of Science Grand Forks, North Dakota January 2018 NON-PHARMACOLOGICAL INTERVENTION FOR SUNDOWNING BEHAVIOR 2 Abstract Dementia patients commonly experience sundowning behavior which includes the following symptoms: restlessness, agitation, aggression, anxiety, swearing and confusion (NIH, 2013). Bachman and Rabins (2005) claim that in the U.S., 13% of dementia patients who experience sundowning behavior live in nursing homes and 66% live in community dwellings. Disruptive behaviors can burden caregivers and eventually institutionalize clients. The etiology of sundowning behaviors is unknown and there may be multiple factors such as, unmet physiological, emotional and psychological needs (NIH, 2013). American Psychiatric Association (APA) guidelines (2014) for the treatment of dementia recommend the use of psychosocial interventions to improve and maintain cognition, mood, behavior and quality of life. -
Dr. Karen Jaffe: Hi Everyone, and Thanks for Joining Us
Dr. Karen Jaffe: Hi everyone, and thanks for joining us. I'm Dr. Karen Jaffe, a member of The Michael J. Fox Foundation Patient Council. I'm also a founder of InMotion, an amazing wellness center for people with Parkinson's Disease located in Cleveland and your moderator for today's very timely webinar. While we won't have time to discuss how world events are causing many of us to have mood changes, today we will be discussing how and why mood changes such as depression and anxiety happen in Parkinson's, how you and your loved ones can talk about these symptoms with each other and with your providers, and what treatment options are available. You can type any questions in the Q and A box near the middle of your screen. We'll get to as many as we can. And if you want the slides for download or for other helpful information, please check the resource list on your screen. There's our list of what we're going to try to talk about. We'll see what we can get to. Go to the next slide, please. We do have a lot to discuss, so let's get started. First, let me introduce our panelists. Sebastian Krys is an 18 times Grammy award winner and CEO of Rebeleon Entertainment. He was diagnosed with Parkinson's disease in 2019. Thanks for joining us, Sebastian. Sebastian Krys: It's good to be here. Dr. Karen Jaffe: Thanks. Roseanne Dobkin as an associate professor of psychiatry at Robert Wood Johnson Medical School at Rutgers University. -
Textbook of Disaster Psychiatry
Textbook of Disaster Psychiatry Edited by Robert J. Ursano Carol S. Fullerton Uniformed Services University of the Health Sciences Lars Weisaeth University of Oslo Beverley Raphael University of Western Sydney CAMBRIDGE UNIVERSITY PRESS I Assessment and management of medical-surgical disaster· casualties James R. Rundell Introduction identify how postdisaster patient triage and manage ment can incorporate behavioral/psychiatric assess Having medical or surgical injuries or conditions ment and treatment, merging behavioral and following a disaster or terrorist attack increases the medical approaches in the differential diagnosis likelihood a psychiatric condition is also present. and early management of common psychiatric syn Fear of exposure to toxic agents can drive many dromes among medical-surgical disaster or terrorism times more patients to medical facilities than actual casualties. terrorism-related toxic exposures. Existing post disaster and post-terrorism algorithms consider pre dominantly medical and surgical triage and patient Phases of individual and community management. There are few specific empirical data responses to terrorism and disasters: about the potential effectiveness of neuropsychiatric integrating psychiatric management triage and treatment integrated into the medical into disaster victim medical-surgical surgical triage and management processes (Burkle, triage and treatment 1991). This is unfortunate, since there are lines of evidence to suggest that early identification of Disasters include natural disasters as well as human psychiatric casualties can help decrease medical made disasters such as terrorist attacks with explo surgical treatment burden, decrease inappropriate sives, chemicals, and biological agents. In cases of treatments of patients, and possibly decrease long disaster or terrorism, particularly when the scope of term psychological sequelae in some patients potential casualties could overwhelm local response (Rundell, 2000). -
Upmcrehab Grand Rounds
WINTER 2012 UPMCREHAB GRAND ROUNDS accreditation statement The University of Pittsburgh School of Medicine is accredited by the Identifying and Managing Accreditation Council for Continuing Medical Education (ACCME) to Agitated Behaviors Following provide continuing medical education for physicians. Traumatic Brain Injury The University of Pittsburgh School of Medicine designates this enduring CaRa CamIolo REddy, MD material for a maximum of 1.0 AMA Medical Director, UPMC Rehabilitation Institute Brain Injury Program PRA Category 1 Credits™. Each Associate Medical Director, UPMC Rehabilitation Network physician should only claim credit commensurate with the extent of Justin HoNg, MD their participation in the activity. Brain Injury Fellow Other health care professionals are Henry Huie, MD awarded 0.1 continuing education Brain Injury Fellow units (CEU) which are equivalent to 1.0 contact hours. disclosures Clinical Vignette Doctors Reddy, Hong, and Huie have reported no relationships with JD is a 24-year-old, right-hand dominant female who incurred traumatic injuries from a proprietary entities producing health bicycle accident. She was traveling approximately 25 mph when she lost control of her bicycle care goods or services. and flew forward over the handlebars, rolling several times. JD was helmeted and sustained a Instructions To take the CME evaluation and brief loss of consciousness at the scene. En route to the hospital, she was intubated for altered receive credit, please visit mental status and combativeness. A head CT UPMCPhysicianResources.com/ demonstrated subarachnoid hemorrhage in the Rehab and click on the course Rehab Grand Rounds Winter 2012. interpeduncular cistern and small areas of acute intraparenchymal hemorrhage, the largest measuring 6 mm in diameter in the right frontal region. -
Blood Biomarkers for Memory: Toward Early Detection of Risk for Alzheimer Disease, Pharmacogenomics, and Repurposed Drugs
Molecular Psychiatry (2020) 25:1651–1672 https://doi.org/10.1038/s41380-019-0602-2 IMMEDIATE COMMUNICATION Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs 1,2,3 1 1 1,3,4 1 1 1 3 A. B. Niculescu ● H. Le-Niculescu ● K. Roseberry ● S. Wang ● J. Hart ● A. Kaur ● H. Robertson ● T. Jones ● 3 3,5 5 2 1 1,4 4 A. Strasburger ● A. Williams ● S. M. Kurian ● B. Lamb ● A. Shekhar ● D. K. Lahiri ● A. J. Saykin Received: 25 March 2019 / Revised: 25 September 2019 / Accepted: 11 November 2019 / Published online: 2 December 2019 © The Author(s) 2019. This article is published with open access Abstract Short-term memory dysfunction is a key early feature of Alzheimer’s disease (AD). Psychiatric patients may be at higher risk for memory dysfunction and subsequent AD due to the negative effects of stress and depression on the brain. We carried out longitudinal within-subject studies in male and female psychiatric patients to discover blood gene expression biomarkers that track short term memory as measured by the retention measure in the Hopkins Verbal Learning Test. These biomarkers were subsequently prioritized with a convergent functional genomics approach using previous evidence in the field implicating them in AD. The top candidate biomarkers were then tested in an independent cohort for ability to predict state short-term memory, 1234567890();,: 1234567890();,: and trait future positive neuropsychological testing for cognitive impairment. The best overall evidence was for a series of new, as well as some previously known genes, which are now newly shown to have functional evidence in humans as blood biomarkers: RAB7A, NPC2, TGFB1, GAP43, ARSB, PER1, GUSB, and MAPT. -
A Conversation with Suzy Bogguss by Frank Goodman (12/2007, Puremusic.Com) What a Singer. When, Only Now and Then, a Singer's Ba
A Conversation with Suzy Bogguss by Frank Goodman (12/2007, puremusic.com) What a singer. When, only now and then, a singer's basic sound is completely arresting, it's like a wake up call. You can have attitude, you can be dramatic, elastic or gymnastic-- but when you have that sound, you can just sing, and it's all there. You can dial in degrees of whatever else you want, but that's just icing on the cake. And it's the cake they call angel's or devil's food, right? A dozen or so albums into a charmed career, Suzy says she's just realizing she's actually the thread that ties it all together, not whether she's singing Country, or Swing, or Jazzy Pop. And the last of those is the place where Sweet Danger goes with assured poise. Though most of her fantastic work has been in the Country vein, her fans followed her when she cut the landmark Swing record with her old friend Ray Benson and past and present members of Asleep At The Wheel. It's a cinch that they will be along for the ride here to witness Suzy absolutely killing the great Beth Nielsen Chapman and Annie Roboff song "Right Back Into The Feeling," or the mindblowing cover of the Peter Cetera classic "If You Leave Me Now." Sometimes you don't really get how great a singer is until they come out of the bag that made them famous. We said jazzy pop, but at times it feels also like a really great soft rock album.